Erythrocytes, immuno-modulation and G6PD deficiency

红细胞、免疫调节和 G6PD 缺乏

基本信息

项目摘要

DESCRIPTION (provided by applicant): It is becoming well appreciated that genetic polymorphism has a major impact on the inflammatory response. Glucose-6-phophate dehydrogenase (G6PD) deficiency is the most common known human genetic polymorphism. G6PD deficiency has a major impact on the host response to trauma and infections and protects against malaria infection. The cellular and biochemical mechanisms responsible for the immuno-modulatory effects of G6PD deficiency are not known. Our general hypothesis is that a compromised antioxidant defense in G6PD deficient erythrocytes and in activated white blood cells alters macrophage activation and subsequent T-cell responses during infections. The studies will employ a septic rodent model (cecal ligation and puncture) in the G6PD deficient mouse. In the context of the most common forms of human G6PD deficiencies, the proposed mouse line is relevant because the residual cellular G6PD activity in the deficient mice is similar to that of the human African, type A- G6PD deficiencies. The proposed hypotheses will test (in general) whether (1) macrophage activation and T lymphocyte polarization are different between G6PD deficient and non-deficient animals. These will be tested in vitro as well as in vivo using the cecal ligation and puncture model. (2) We will also investigate wether the sepsis induced erythrocyte damage is more pronounced in G6PD deficiency. The effects of G6PD deficiency on the sepsis-induced organ inflammatory responses and damage, as well as, mortality will also be tested. Additionally, we will investigate (3) whether antioxidant and anti nitric oxide therapies will be beneficial in G6PD deficiency during sepsis. In view of the well-known early oxidative stress and erythrocyte damage during infections and the importance of macrophage and T-cell responses in the inflammatory response the investigated questions are novel and important and may benefit all trauma patients. Elucidating these questions in the context of G6PD deficiency brings in a highly relevant clinical aspect; furthermore, this also provides a unique opportunity to test the relationship between erythrocyte dysfunction and the modulation of the innate immune response. Elucidation of macrophage and T-cell cytokine responses to infection in G6PD deficiency may also be important in providing a mechanism of malaria protection alternative to currently accepted notions.
描述(由申请人提供): 遗传多态性对炎症反应具有重要影响,这一点已被广泛认识。葡萄糖-6-磷酸脱氢酶(G6 PD)缺乏症是已知最常见的人类遗传多态性。G6 PD缺陷对宿主对创伤和感染的反应有重大影响,并可防止疟疾感染。负责G6 PD缺乏的免疫调节作用的细胞和生化机制尚不清楚。我们的一般假设是,在G6 PD缺乏的红细胞和活化的白色血细胞中,受损的抗氧化防御改变了感染期间巨噬细胞的活化和随后的T细胞反应。研究将在G6 PD缺陷小鼠中采用脓毒症啮齿动物模型(盲肠结扎和穿孔)。在最常见形式的人G6 PD缺陷的背景下,所提出的小鼠系是相关的,因为缺陷小鼠中的残留细胞G6 PD活性与非洲人A型G6 PD缺陷相似。所提出的假设将测试(一般而言)G6 PD缺陷型和非缺陷型动物之间(1)巨噬细胞活化和T淋巴细胞极化是否不同。将使用盲肠结扎和穿刺模型在体外和体内对这些进行测试。(2)我们还将研究脓毒症诱导的红细胞损伤是否在G6 PD缺乏症中更明显。还将测试G6 PD缺乏对脓毒症诱导的器官炎症反应和损伤以及死亡率的影响。此外,我们将研究(3)抗氧化剂和抗一氧化氮治疗是否对脓毒症期间的G6 PD缺陷有益。鉴于众所周知的早期氧化应激和红细胞损伤在感染和巨噬细胞和T细胞反应的重要性,在炎症反应的调查问题是新的和重要的,可能有利于所有创伤患者。在G6 PD缺乏症的背景下阐明这些问题带来了高度相关的临床方面;此外,这也提供了一个独特的机会来测试红细胞功能障碍和先天免疫应答调节之间的关系。阐明巨噬细胞和T细胞细胞因子对G6 PD缺乏症感染的反应也可能是重要的,在提供一种机制,疟疾保护替代目前接受的概念。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ZOLTAN SPOLARICS其他文献

ZOLTAN SPOLARICS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ZOLTAN SPOLARICS', 18)}}的其他基金

X chromosome, injury and infection
X染色体、损伤和感染
  • 批准号:
    8241156
  • 财政年份:
    2009
  • 资助金额:
    $ 26.54万
  • 项目类别:
X chromosome, injury and infection
X染色体、损伤和感染
  • 批准号:
    7797529
  • 财政年份:
    2009
  • 资助金额:
    $ 26.54万
  • 项目类别:
X chromosome, injury and infection
X染色体、损伤和感染
  • 批准号:
    8054855
  • 财政年份:
    2009
  • 资助金额:
    $ 26.54万
  • 项目类别:
Erythrocytes, immuno-modulation and G6PD deficiency
红细胞、免疫调节和 G6PD 缺乏
  • 批准号:
    6938546
  • 财政年份:
    2004
  • 资助金额:
    $ 26.54万
  • 项目类别:
Erythrocytes, immuno-modulation and G6PD deficiency
红细胞、免疫调节和 G6PD 缺乏
  • 批准号:
    7117175
  • 财政年份:
    2004
  • 资助金额:
    $ 26.54万
  • 项目类别:
Erythrocytes, immuno-modulation and G6PD deficiency
红细胞、免疫调节和 G6PD 缺乏
  • 批准号:
    6821071
  • 财政年份:
    2004
  • 资助金额:
    $ 26.54万
  • 项目类别:
TRAUMA, G6PD DEFICIENCY AND SEPSIS
创伤、G6PD 缺乏症和败血症
  • 批准号:
    2655021
  • 财政年份:
    1997
  • 资助金额:
    $ 26.54万
  • 项目类别:
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND SEPSIS
6-磷酸葡萄糖脱氢酶缺乏症和脓毒症
  • 批准号:
    6628867
  • 财政年份:
    1997
  • 资助金额:
    $ 26.54万
  • 项目类别:
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND SEPSIS
6-磷酸葡萄糖脱氢酶缺乏症和脓毒症
  • 批准号:
    6698545
  • 财政年份:
    1997
  • 资助金额:
    $ 26.54万
  • 项目类别:
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND SEPSIS
6-磷酸葡萄糖脱氢酶缺乏症和脓毒症
  • 批准号:
    6498741
  • 财政年份:
    1997
  • 资助金额:
    $ 26.54万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 26.54万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.54万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 26.54万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.54万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 26.54万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.54万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 26.54万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 26.54万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 26.54万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.54万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了